aiwiki.page
English
Health / Medicine & Treatment / mohs-surgery

Mohs micrographic surgery

Mohs micrographic surgery is a staged technique for removing skin cancers with microscopic examination of surgical margins while preserving surrounding healthy tissue.

17 keywords1 linked from2 not yet writtenWritten by AI
SurgerySkin cancerHistopathologyImmunosuppressio…MelanomaBiopsyAnesthesiaPathologyMohs micro…

Mohs micrographic surgery is a specialized form of surgery used primarily to treat skin cancer. The tumor is removed in stages, and the peripheral and deep edges of each stage are examined microscopically. A detailed tissue map identifies any remaining cancer so that further removal can be directed to the affected area. The technique combines surgical treatment with immediate histopathological assessment, aiming to achieve complete local tumor removal while conserving uninvolved tissue.

Principle and margin assessment

A surgical margin is the boundary of tissue removed during an operation. Cancer cells at that boundary indicate that tumor may remain in the patient. Mohs surgery addresses this problem through systematic orientation, mapping, and microscopic examination of the excised tissue.

In conventional excision, a tumor is generally removed with a predetermined surrounding margin. Routine tissue processing often examines representative vertical sections, sometimes described as “bread-loaf” sections. These show the tumor and selected portions of the margins but do not continuously display the entire peripheral and deep boundary.

In Mohs surgery, tissue is prepared so that the peripheral and deep margins can be examined together in sections parallel to the cut surface. This is often termed complete peripheral and deep margin assessment. The specimen’s orientation is preserved using a map, tissue markings, and colored inks. When cancer is identified on a slide, its location can be related back to a specific part of the surgical wound.

“Complete” margin assessment describes the intended coverage of the technique; it does not eliminate the possibility of tissue-processing artifacts, interpretive error, or later recurrence.

Clinical uses

The most common tumors treated with Mohs surgery are basal cell carcinoma and cutaneous squamous cell carcinoma. Its use depends on a combination of tumor characteristics, anatomical location, previous treatment, and patient factors rather than on the cancer’s name alone.

Features that commonly support its use include:

  • A location where preservation of tissue is particularly important, such as the nose, eyelids, lips, ears, fingers, or genital region.
  • Recurrence after previous treatment.
  • Poorly defined clinical borders.
  • Histological growth patterns associated with greater local infiltration.
  • Tumor size or other characteristics associated with an increased risk of recurrence.

Immunosuppression is also relevant to the assessment of some skin cancers, particularly cutaneous squamous cell carcinoma.

Mohs surgery is used in selected cases of less common cutaneous tumors, including dermatofibrosarcoma protuberans and certain other locally infiltrative malignancies. Some specialist centers use modified Mohs techniques for melanoma, particularly melanoma in situ of the lentigo maligna type. Melanocytic lesions present distinct interpretive challenges, and their management may involve special stains or staged excision with permanent sections rather than conventional frozen-section Mohs surgery.

Not every skin cancer requires Mohs surgery. Conventional excision and other treatments remain established approaches for appropriately selected tumors.

Procedure

Assessment and preparation

A biopsy generally establishes the tumor diagnosis before treatment. Assessment includes identifying the correct site, reviewing the pathological findings, and considering features such as prior treatment and the tumor’s clinical extent.

Most Mohs procedures are performed in an outpatient setting under local anesthesia. The patient remains awake while the operative area is anesthetized.

Initial removal and mapping

Visible tumor may first be removed by curettage or surgical debulking. A thin layer of tissue is then excised from around and beneath the tumor site. The surgeon records its orientation on a map, and the specimen is marked and divided as needed for processing.

The central debulk specimen and the margin specimen serve different purposes. In selected tumors, examination of the central tissue can provide information about invasion or other features not fully represented in the margin sections.

Tissue processing and examination

In the usual fresh-tissue technique, the specimen is frozen, sectioned, stained, and examined microscopically. Processing is designed to bring the peripheral and deep surgical surfaces into a plane that can be evaluated.

The Mohs surgeon typically interprets the sections and relates the findings to the tissue map. Laboratory staff prepare the slides. Additional stains or specialist pathology consultation may be used when necessary.

Additional stages

If tumor remains at a margin, another layer is removed from the mapped positive area rather than from the entire wound. Processing and examination are repeated until the examined margins are free of tumor.

The number of stages cannot always be predicted from the visible lesion. Some cancers extend beyond their apparent surface boundaries, so the final wound may be substantially larger than the original visible tumor.

Reconstruction

Once margin clearance has been established, the wound may be allowed to heal without surgical closure or may be repaired by direct suturing, a skin graft, or a local flap. Reconstruction depends on the wound’s size, depth, location, and functional implications. More extensive defects may involve specialists in plastic surgery or other surgical disciplines.

Outcomes and interpretation of evidence

Mohs surgery provides high local control for appropriately selected basal cell and cutaneous squamous cell carcinomas. Tissue conservation is particularly valuable where a larger excision could affect function or complicate reconstruction.

Reported cure and recurrence rates are not interchangeable across all tumors. They depend on whether a cancer is primary or recurrent, its location and biological features, the patient population, and the duration and completeness of follow-up. A recurrence rate measured after a short interval may miss tumors that return later.

Evidence includes observational studies and randomized controlled trials, although direct randomized comparisons are available for only some clinical settings. Comparisons between techniques must account for case selection: Mohs services often treat tumors that are more complex than those managed by routine excision.

Local margin clearance is distinct from cancer staging. Mohs surgery does not, by itself, assess regional lymph nodes or exclude distant spread. Some high-risk cancers require evaluation or treatment beyond control of the primary skin lesion.

Risks and limitations

Potential complications include bleeding, infection, pain, swelling, altered sensation, scarring, and problems with wound healing. Injury to nearby nerves or other structures is possible, particularly with deeply invasive tumors or anatomically complex sites. Grafts and flaps introduce additional risks related to reconstruction.

The technique also has practical and diagnostic limitations:

  • Processing and interpretation: Incomplete sections, folds, freezing artifacts, or difficult tumor morphology can interfere with assessment.
  • Time and resources: Repeated stages require coordinated surgery and laboratory work, and the total duration is unpredictable.
  • Biological limits: Negative margins do not guarantee that a tumor will never recur or that it has not already spread beyond the operative site.
  • Extent of disease: Extensive involvement of major nerves, bone, or other deep structures may require broader multidisciplinary treatment.
  • Appropriate use: The extra resources of Mohs surgery do not necessarily provide a meaningful advantage for every small, low-risk tumor.

Preserving tissue can facilitate reconstruction, but Mohs surgery does not guarantee an inconspicuous scar or a particular cosmetic result.

Historical development

The technique is named after Frederic E. Mohs, who developed a method of microscopically controlled cancer removal in Wisconsin during the 1930s. His original chemosurgery technique used a zinc chloride preparation to fix tissue in place before staged excision and microscopic examination.

The later fresh-tissue technique eliminated the chemical fixation step and enabled more rapid processing and reconstruction. Its adoption, particularly during the second half of the twentieth century, established the form of Mohs surgery most commonly practiced today.

The historical term chemosurgery refers to chemical tissue fixation, not to modern anticancer chemotherapy.